Analyst Ratings for Pfizer (PFE)
PFE Rating Summary
PFE Price Target Summary
- Highest: $53.00 (Cantor Fitzgerald)
- Lowest: $36.00 (JPMorgan)
- Average: $41.47
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$41.47 (+3.4%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 39%
Rating Score: 4.1 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/6/2021 | Mizuho Securities | Vamil Divan | Downgrade | Neutral (Buy) |
42.00 (N/A) |
39.95 (40.10) |
0.38% | Details |
| 4/7/2021 | RBC Capital » Updated 5/5/2021 |
Daniel Busb | New Coverage | Sector Perform (N/A) |
43.00 (42.00) |
36.28 (40.10) |
10.53% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
PFE Ratings News
- UPDATE: Pfizer (PFE) PT Raised to $42 at Morgan Stanley on Much Higher Vaccine Sales Projections
- Pfizer (PFE) Down on Potential IP Wavers, Mizuho Downgrades to 'Neutral' as it Sees No Clear Drivers of Meaningful Upside
- UPDATE: Mizuho Securities Downgrades Pfizer (PFE) to Neutral on Balanced Risk/Reward
- See More
